Contact this trialFirst, we need to learn more about you.
Angiotensin II Receptor Blocker
SZC for Chronic Kidney Disease
Recruiting1 awardPhase 3
Fort Wayne, Indiana
This trial will test whether a new drug, Sodium Zirconium Cyclosilicate (SZC), can help slow down kidney disease progression in people who are at risk for hyperkalaemia (high potassium levels).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.